nirsevimab
After GSK stumble, Pfizer moves forward with RSV vaccine
Phil Taylor
AstraZeneca, GlaxoSmithKline, nirsevimab, Pfizer, respiratory syncytial virus, Sanofi, SOBI, Synagis, vaccine
0 Comment
X
After GSK stumble, Pfizer moves forward with RSV vaccine
https://pharmaphorum.com/news/after-gsk-stumble-pfizer-moves-forward-with-rsv-vaccine/
AZ, Sanofi prep filings for one-shot RSV antibody after trial win
Phil Taylor
AstraZeneca, GlaxoSmithKline, nirsevimab, respiratory syncytial virus, Sanofi, SOBI, Synagis, vaccine
0 Comment
X
AZ, Sanofi prep filings for one-shot RSV antibody after trial win
https://pharmaphorum.com/news/az-sanofi-prep-filings-for-one-shot-rsv-antibody-after-trial-win/